Endospan Secures FDA Approval for NEXUS® Aortic Arch Stent Graft System

Endospan achieves FDA Approval for NEXUS® Aortic Arch Stent Graft System, Expanding Minimally Invasive Options for High-Risk Patients Endospan, a privately held medical device company based in Tel Aviv, Israel, has reached a significant regulatory milestone with the approval of…










